Nils Regge

Nils Regge is the Co-Founder and General Partner at Apollo Health Ventures, a transatlantic early-stage venture capital firm. With over 25 years of experience in venture capital, he previously founded the venture creation firm TruVenturo in 2010, where he co-founded more than 15 companies. During his tenure at TruVenturo, Regge led six startups to successful exits and guided three companies to valuations exceeding $100 million, working alongside co-investors like Insight Venture Partners and Highland Capital. He currently serves as a board director for portfolio companies including Aeovian Pharmaceuticals and Samsara Therapeutics, and his educational background includes studies at the University of Hamburg, UC Santa Barbara, and the Massachusetts Institute of Technology. Regge focuses his current investment strategy on scaling early-stage biotechnology startups that develop solutions for aging biology and age-related diseases.